Biocorrx Inc (BICX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Sales | 40 | 83 | 94 | 16 | 21 |
| Cost of Goods | 9 | 9 | 2 | 3 | 2 |
| Gross Profit | 32 | 74 | 92 | 13 | 19 |
| Operating Expenses | 1,097 | 1,269 | 1,124 | 1,374 | 1,145 |
| Operating Income | -1,056 | -1,186 | -1,029 | -1,358 | -1,125 |
| Interest Expense | 195 | 194 | 253 | 472 | 167 |
| Other Income | 241 | 217 | 331 | 513 | 347 |
| Pre-tax Income | -1,011 | -1,163 | -951 | -1,318 | -945 |
| Net Income Continuous | -1,011 | -1,163 | -951 | -1,318 | -945 |
| Minority Interests | 1 | 3 | 2 | 2 | 1 |
| Net Income | $-1,012 | $-1,166 | $-953 | $-1,320 | $-946 |
| EPS Basic Total Ops | -0.13 | -0.15 | -0.13 | -0.19 | -0.14 |
| EPS Basic Continuous Ops | -0.13 | -0.15 | -0.13 | -0.19 | -0.14 |
| EPS Diluted Total Ops | -0.13 | -0.15 | -0.13 | -0.19 | -0.14 |
| EPS Diluted Continuous Ops | -0.13 | -0.15 | -0.13 | -0.19 | -0.14 |
| EBITDA(a) | $-881 | $-1,087 | $-795 | $-1,205 | $-975 |